Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries
- PMID: 23173757
- PMCID: PMC3594455
- DOI: 10.1111/1753-0407.12014
Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries
Abstract
Background: The aim of the present study was to examine the association between antidepressant use, diagnosed depression, and new-onset diabetes among elderly Medicare beneficiaries.
Methods: Longitudinal data from merged survey and claims from the nationally representative Medicare Current Beneficiary Survey(MCBS) from 1999 to 2005 were used. Diabetes incidence was extracted from claims and survey data over a 3-year period. Data regarding depression and antidepressant use over time were obtained. Multivariate logistic regression analysis was used to examine associations between antidepressant use, depression, and new-onset diabetes, adjusted for demographic, socioeconomic, and lifestyle risk factors. Analyses accounted for the complex design of the MCBS.
Results: The incident diabetes rate was 4.8% for those "without depression and without antidepressants" and 9.5% for those with any antidepressant use in all 3 years and diagnosed depression". Compared with Medicare beneficiaries who did not report any antidepressant use, beneficiaries reporting antidepressant use in all 3 years were 50% more likely to have new-onset diabetes. However, when diagnosed depression was entered in the model, there was no significant association between long-term antidepressant use and new-onset diabetes. Medicare beneficiaries with any depression were twice as likely as those without depression to develop diabetes (adjusted odds ratio 2.04; 95% confidence interval 1.51, 2.75).
Conclusions: Depression independently increased the risk of developing diabetes in the MCBS population, although there is no evidence of an association between antidepressant use and new-onset diabetes. If replicated, these results have significant clinical implications.
Keywords: antidepressants; depression; diabetes; elderly; epidemiology; 抗抑郁药,抑郁症,糖尿病,老年人,流行病学.
© 2012 Wiley Publishing Asia Pty Ltd and Ruijin Hospital, Shanghai Jiaotong University School of Medicine.
Similar articles
-
Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.Med Care. 2003 Jan;41(1):180-94. doi: 10.1097/00005650-200301000-00019. Med Care. 2003. PMID: 12544554
-
Diagnosis and treatment of depression in the elderly medicare population: predictors, disparities, and trends.J Am Geriatr Soc. 2003 Dec;51(12):1718-28. doi: 10.1046/j.1532-5415.2003.51555.x. J Am Geriatr Soc. 2003. PMID: 14687349 Free PMC article.
-
Associations of depression diagnosis and antidepressant treatment with mortality among young and disabled Medicare beneficiaries with COPD.Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):612-8. doi: 10.1016/j.genhosppsych.2013.06.005. Epub 2013 Jul 18. Gen Hosp Psychiatry. 2013. PMID: 23871313
-
Depression and cost-related medication nonadherence in Medicare beneficiaries.Arch Gen Psychiatry. 2007 May;64(5):602-8. doi: 10.1001/archpsyc.64.5.602. Arch Gen Psychiatry. 2007. PMID: 17485612
-
Diabetes and depression care among medicaid beneficiaries.J Health Care Poor Underserved. 2006 Feb;17(1):141-61. doi: 10.1353/hpu.2006.0034. J Health Care Poor Underserved. 2006. PMID: 16520523
Cited by
-
Depression, antidepressant use, and the risk of type 2 diabetes: a nationally representative cohort study.Front Psychiatry. 2023 Dec 6;14:1275984. doi: 10.3389/fpsyt.2023.1275984. eCollection 2023. Front Psychiatry. 2023. PMID: 38125283 Free PMC article.
-
Role of Serotonin Transporter in Antidepressant-Induced Diabetes Mellitus: A Pharmacoepidemiological-Pharmacodynamic Study in VigiBase®.Drug Saf. 2018 Nov;41(11):1087-1096. doi: 10.1007/s40264-018-0693-8. Drug Saf. 2018. PMID: 29956218
-
The risk of new-onset diabetes in antidepressant users - A systematic review and meta-analysis.PLoS One. 2017 Jul 31;12(7):e0182088. doi: 10.1371/journal.pone.0182088. eCollection 2017. PLoS One. 2017. PMID: 28759599 Free PMC article. Review.
-
Impact of Muscarinic M3 Receptor Antagonism on the Risk of Type 2 Diabetes in Antidepressant-Treated Patients: A Case-Controlled Study.CNS Drugs. 2017 Jun;31(6):483-493. doi: 10.1007/s40263-017-0436-x. CNS Drugs. 2017. PMID: 28527131 Free PMC article.
-
Concomitant Medication Use and New-Onset Diabetes Among Medicaid Beneficiaries with Chronic Obstructive Pulmonary Disease.Popul Health Manag. 2017 Jun;20(3):224-232. doi: 10.1089/pop.2016.0047. Epub 2016 Sep 30. Popul Health Manag. 2017. PMID: 27689453 Free PMC article.
References
-
- Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Archives of General Psychiatry. 2009;66:848–56. - PubMed
-
- Brown LC, Majumdar SR, Johnson JA. Type of antidepressant therapy and risk of type 2 diabetes in people with depression. Diabetes Research & Clinical Practice. 2008;79:61–7. - PubMed
-
- Andersohn F, Schade R, Suissa S, Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. The American Journal of Psychiatry. 2009;166:591–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
